a developer of novel bacteriophage-based therapeutics
Industry Biotechnology
A.I.dvisor tells us that ARMP and FRES have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and FRES's prices will move in lockstep.
Ticker / NAME | Correlation To ARMP | 1D Price Change % | ||
---|---|---|---|---|
ARMP | 100% | +2.39% | ||
FRES - ARMP | 24% Poorly correlated | +0.24% | ||
RAPT - ARMP | 24% Poorly correlated | -1.27% | ||
CVAC - ARMP | 23% Poorly correlated | +1.53% | ||
ALGS - ARMP | 22% Poorly correlated | +1.71% | ||
FRTX - ARMP | 21% Poorly correlated | +4.35% | ||
More |